| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| John B Buckwalter, Jason J Hamann, Philip S Cliffor. Neuropeptide Y1 receptor vasoconstriction in exercising canine skeletal muscles. Journal of applied physiology (Bethesda, Md. : 1985). vol 99. issue 6. 2006-01-05. PMID:16099895. |
existing evidence suggests that neuropeptide y (npy) acts as a neurotransmitter in vascular smooth muscle and is coreleased with norepinephrine from sympathetic nerves. |
2006-01-05 |
2023-08-12 |
Not clear |
| Andrew Holmes, Anne Marie le Guisquet, Elise Vogel, Rachel A Millstein, Samuel Leman, Catherine Belzun. Early life genetic, epigenetic and environmental factors shaping emotionality in rodents. Neuroscience and biobehavioral reviews. vol 29. issue 8. 2005-12-15. PMID:16095695. |
in rats, postnatal maternal separation can produce lasting increases in emotional behavior and stressor-reactivity, together with alterations in various brain neurotransmitter systems implicated in emotionality, including corticotropin-releasing factor, serotonin, norepinephrine, and glutamate. |
2005-12-15 |
2023-08-12 |
mouse |
| Hiroshi Hasegawa, Romain Meeusen, Sophie Sarre, Marc Diltoer, Maria Francesca Piacentini, Yvette Michott. Acute dopamine/norepinephrine reuptake inhibition increases brain and core temperature in rats. Journal of applied physiology (Bethesda, Md. : 1985). vol 99. issue 4. 2005-12-01. PMID:15920099. |
the purpose of the present study was to examine the effects of an acute dose of the dual dopamine (da) and norepinephrine (ne) reuptake inhibitor bupropion (bup) on brain (t(brain)), body core (t(core)), and tail skin (t(tail)) temperature in freely moving rats and to simultaneously monitor the extracellular neurotransmitter concentrations in the preoptic area and anterior hypothalamus (po/ah). |
2005-12-01 |
2023-08-12 |
rat |
| Jeff D Sanders, H Kevin Happe, L Charles Murri. A transient expression of functional alpha2-adrenergic receptors in white matter of the developing brain. Synapse (New York, N.Y.). vol 57. issue 4. 2005-10-27. PMID:15986363. |
norepinephrine is a neurotransmitter with peripheral and central actions mediated by alpha-1, alpha-2, and beta-adrenergic receptors. |
2005-10-27 |
2023-08-12 |
rat |
| Katherine L Holton, Merewyn K Loder, Haley E Melikia. Nonclassical, distinct endocytic signals dictate constitutive and PKC-regulated neurotransmitter transporter internalization. Nature neuroscience. vol 8. issue 7. 2005-09-20. PMID:15924135. |
the dat internalization signal is conserved across slc6 neurotransmitter carriers and is functional in the homologous norepinephrine transporter, suggesting that this region is likely to be the endocytic signal for all slc6 neurotransmitter transporters. |
2005-09-20 |
2023-08-12 |
Not clear |
| Jong-So Kim, Steven L Coon, Seth Blackshaw, Constance L Cepko, Morten Møller, Sujira Mukda, Wan-Qian Zhao, Clivel G Charlton, David C Klei. Methionine adenosyltransferase:adrenergic-cAMP mechanism regulates a daily rhythm in pineal expression. The Journal of biological chemistry. vol 280. issue 1. 2005-07-21. PMID:15504733. |
mat2a mrna and mat ii protein were increased in organ culture by treatment with norepinephrine (ne), the sympathetic neurotransmitter that stimulates the pineal gland at night. |
2005-07-21 |
2023-08-12 |
Not clear |
| J N Mason, H Farmer, I D Tomlinson, J W Schwartz, V Savchenko, L J DeFelice, S J Rosenthal, R D Blakel. Novel fluorescence-based approaches for the study of biogenic amine transporter localization, activity, and regulation. Journal of neuroscience methods. vol 143. issue 1. 2005-06-30. PMID:15763132. |
pre-synaptic norepinephrine (ne) and dopamine (da) transporters (net and dat) terminate catecholamine synaptic transmission through reuptake of released neurotransmitter. |
2005-06-30 |
2023-08-12 |
Not clear |
| M Claire Cartford, Amy Samec, Mathew Fister, Paula C Bickfor. Cerebellar norepinephrine modulates learning of delay classical eyeblink conditioning: evidence for post-synaptic signaling via PKA. Learning & memory (Cold Spring Harbor, N.Y.). vol 11. issue 6. 2005-03-15. PMID:15537737. |
the neurotransmitter norepinephrine (ne) has been shown to modulate cerebellar-dependent learning and memory. |
2005-03-15 |
2023-08-12 |
Not clear |
| Darius K Shayegan, Stephen M Stah. Atypical antipsychotics: matching receptor profile to individual patient's clinical profile. CNS spectrums. vol 9. issue 10 Suppl 11. 2005-01-04. PMID:15475871. |
atypical antipsychotics also interact with noradrenergic (alpha 1- and alpha 2-adrenergic receptor blockade), histaminergic (h1-receptor blockade), and cholinergic (muscarinic m1 blockade) neurotransmitter systems as well as with monoamine (d, 5-ht, and norepinephrine reuptake blockade) transporters. |
2005-01-04 |
2023-08-12 |
Not clear |
| Marcelo Vatta, Clara Peña, Belisario E Fernández, Georgina Rodríguez de Lores Arnai. Endobain E, a brain Na+, K+ -ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus. Life sciences. vol 76. issue 4. 2004-12-07. PMID:15530498. |
endobain e effect on neurotransmitter uptake was studied by assaying [3h]norepinephrine uptake in rat hypothalamus preparations, to observe uptake inhibition, which reached 60% with endobain e equivalent to 100 mg fresh cerebral cortex, an effect achieved with 40 or 400 microm ouabain. |
2004-12-07 |
2023-08-12 |
rat |
| Marcelo Vatta, Clara Peña, Belisario E Fernández, Georgina Rodríguez de Lores Arnai. Endobain E, a brain Na+, K+ -ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus. Life sciences. vol 76. issue 4. 2004-12-07. PMID:15530498. |
taken jointly results obtained on neurotransmitter release and uptake, the suggestion that endobain e may enhance norepinephrine availability in the synaptic gap and thus lead to an increase in noradrenergic activity is advanced. |
2004-12-07 |
2023-08-12 |
rat |
| E Davids, M Gastpa. [Atomoxetine for the treatment of attention-deficit/hyperactivity disorder]. Fortschritte der Neurologie-Psychiatrie. vol 72. issue 10. 2004-12-06. PMID:15472782. |
in vitro, ex vivo and in vivo studies have shown that atomoxetine is a highly selective antagonist of the presynaptic norepinephrine transporter with little or no affinity for other noradrenergic receptors or other neurotransmitter transporters or receptors. |
2004-12-06 |
2023-08-12 |
Not clear |
| Marc Brede, Gabor Nagy, Melanie Philipp, Jakob B Sorensen, Martin J Lohse, Lutz Hei. Differential control of adrenal and sympathetic catecholamine release by alpha 2-adrenoceptor subtypes. Molecular endocrinology (Baltimore, Md.). vol 17. issue 8. 2004-11-09. PMID:12764077. |
in the adrenergic system, release of the neurotransmitter norepinephrine from sympathetic nerves is regulated by presynaptic inhibitory alpha2-adrenoceptors, but it is unknown whether release of epinephrine from the adrenal gland is controlled by a similar short feedback loop. |
2004-11-09 |
2023-08-12 |
mouse |
| Tsunenori Hirayama, Tomoko Kobayashi, Takehisa Fujita, Osamu Fujin. [Two cases of adult Down syndrome treated with selective serotonin re-uptake inhibitor for behavior disorders]. No to hattatsu = Brain and development. vol 36. issue 5. 2004-11-09. PMID:15461027. |
individuals with down syndrome demonstrate neurotransmitter changes such as the loss of acetylcholine, norepinephrine, and serotonin (5-ht) with increasing age. |
2004-11-09 |
2023-08-12 |
Not clear |
| Matthew E Szapacs, Adam L Numis, Anne M Andrew. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiology of disease. vol 16. issue 3. 2004-09-24. PMID:15262269. |
in the present investigation, which focused on further delineating the effects of amyloid deposition on hippocampal neurochemistry, decreases in serotonin neurotransmitter levels (-25%) were discovered to be present at 18 months in app+/ps1+ mice, while norepinephrine was reduced in the hippocampus of 12- (-30%) and 18-month-old (-45%) app+/ps1+ double mutants. |
2004-09-24 |
2023-08-12 |
mouse |
| Matthew E Szapacs, Adam L Numis, Anne M Andrew. Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1. Neurobiology of disease. vol 16. issue 3. 2004-09-24. PMID:15262269. |
these findings show that early amyloid deposition in mice expressing mutant human app and ps-1 is associated with a progressive loss of serotonin and norepinephrine neurotransmitter levels in the hippocampus later in life. |
2004-09-24 |
2023-08-12 |
mouse |
| Murray Esler, Marlies Alvarenga, Gavin Lambert, David Kaye, Jacqui Hastings, Garry Jennings, Margaret Morris, Rosemary Schwarz, Jeff Richard. Cardiac sympathetic nerve biology and brain monoamine turnover in panic disorder. Annals of the New York Academy of Sciences. vol 1018. 2004-08-18. PMID:15240408. |
we find normal norepinephrine turnover but a marked increase in brain serotonin turnover in patients with panic disorder, in the absence of a panic attack, which presumably represents an underlying neurotransmitter substrate for the condition. |
2004-08-18 |
2023-08-12 |
Not clear |
| John B Buckwalter, Jason J Hamann, Heidi A Kluess, Philip S Cliffor. Vasoconstriction in exercising skeletal muscles: a potential role for neuropeptide Y? American journal of physiology. Heart and circulatory physiology. vol 287. issue 1. 2004-07-23. PMID:15210450. |
there is evidence that neuropeptide y (npy) acts as a neurotransmitter in vascular smooth muscle and is released with norepinephrine from sympathetic nerves. |
2004-07-23 |
2023-08-12 |
Not clear |
| Manuela Di Benedetto, Claudio D'Addario, Stephanie Collins, Sari Izenwasser, Sanzio Candeletti, Patrizia Romuald. Role of serotonin on cocaine-mediated effects on prodynorphin gene expression in the rat brain. Journal of molecular neuroscience : MN. vol 22. issue 3. 2004-06-17. PMID:14997015. |
because neither a selective dopamine uptake inhibitor nor a selective serotonin uptake inhibitor produced the same effect as cocaine in the caudate putamen, this effect is likely regulated by the inhibition of norepinephrine uptake, by a combination of effects on two or three neurotransmitter transporters, or by a mechanism unrelated to transporter inhibition. |
2004-06-17 |
2023-08-12 |
rat |
| Patrick Slama, Jean-Luc Boucher, Marius Réglie. Aromatic N-hydroxyguanidines as new reduction cosubstrates for dopamine beta-hydroxylase. Biochemical and biophysical research communications. vol 316. issue 4. 2004-05-21. PMID:15044095. |
conversion of neurotransmitter dopamine into norepinephrine is catalyzed by dopamine beta-hydroxylase (dbh). |
2004-05-21 |
2023-08-12 |
Not clear |